{"transactions":[{"id":1843380,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":111876,"kind":"organization","name":"MedTech Acquisition Sponsor LLC","position":1,"cik":"0001826760","reported_name":"MedTech Acquisition Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111877,"kind":"person","name":"Dewey Christopher C","position":2,"cik":"0001385015","reported_name":"Dewey Christopher C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":3,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2023-06-27T20:13:30.000Z","date":"2023-06-26","kind":"exercise","planned":false,"acquired":false,"shares":6249999,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Class B common stock, par value $0.0001 per share (\"Class B Common Stock\"), of the issuer are convertible into an equal number of shares of Class A common stock, par value $0.0001 per share (\"Class A Common Stock\"), of the issuer. On June 26, 2023, MedTech Acquisition Sponsor LLC (the \"Sponsor\") elected to convert 6,249,999 shares of their Class B Common Stock into an equal number of Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Class B common stock, par value $0.0001 per share (\"Class B Common Stock\"), of the issuer are convertible into an equal number of shares of Class A common stock, par value $0.0001 per share (\"Class A Common Stock\"), of the issuer. On June 26, 2023, MedTech Acquisition Sponsor LLC (the \"Sponsor\") elected to convert 6,249,999 shares of their Class B Common Stock into an equal number of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Class B common stock, par value $0.0001 per share (\"Class B Common Stock\"), of the issuer are convertible into an equal number of shares of Class A common stock, par value $0.0001 per share (\"Class A Common Stock\"), of the issuer. On June 26, 2023, MedTech Acquisition Sponsor LLC (the \"Sponsor\") elected to convert 6,249,999 shares of their Class B Common Stock into an equal number of Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Class B common stock, par value $0.0001 per share (\"Class B Common Stock\"), of the issuer are convertible into an equal number of shares of Class A common stock, par value $0.0001 per share (\"Class A Common Stock\"), of the issuer. On June 26, 2023, MedTech Acquisition Sponsor LLC (the \"Sponsor\") elected to convert 6,249,999 shares of their Class B Common Stock into an equal number of Class A Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Class B common stock, par value $0.0001 per share (\"Class B Common Stock\"), of the issuer are convertible into an equal number of shares of Class A common stock, par value $0.0001 per share (\"Class A Common Stock\"), of the issuer. On June 26, 2023, MedTech Acquisition Sponsor LLC (the \"Sponsor\") elected to convert 6,249,999 shares of their Class B Common Stock into an equal number of Class A Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor is the record holder of the securities reported herein. Christopher C. Dewey and David J. Matlin are managing members of the Sponsor. By virtue of this relationship, each of these individuals may be deemed to share beneficial ownership of the securities held of record by the Sponsor. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein."}],"balance_after":1,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6249999},"source":{"system":"sec-edgar","filing":"0001104659-23-075256","document":"tm2319584-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000110465923075256/tm2319584-1_4seq1.xml","form_type":"4"}},{"id":1843379,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":111876,"kind":"organization","name":"MedTech Acquisition Sponsor LLC","position":1,"cik":"0001826760","reported_name":"MedTech Acquisition Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111877,"kind":"person","name":"Dewey Christopher C","position":2,"cik":"0001385015","reported_name":"Dewey Christopher C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":3,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-27T20:13:30.000Z","date":"2023-06-26","kind":"exercise","planned":false,"acquired":true,"shares":6249999,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Class B common stock, par value $0.0001 per share (\"Class B Common Stock\"), of the issuer are convertible into an equal number of shares of Class A common stock, par value $0.0001 per share (\"Class A Common Stock\"), of the issuer. On June 26, 2023, MedTech Acquisition Sponsor LLC (the \"Sponsor\") elected to convert 6,249,999 shares of their Class B Common Stock into an equal number of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Class B common stock, par value $0.0001 per share (\"Class B Common Stock\"), of the issuer are convertible into an equal number of shares of Class A common stock, par value $0.0001 per share (\"Class A Common Stock\"), of the issuer. On June 26, 2023, MedTech Acquisition Sponsor LLC (the \"Sponsor\") elected to convert 6,249,999 shares of their Class B Common Stock into an equal number of Class A Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor is the record holder of the securities reported herein. Christopher C. Dewey and David J. Matlin are managing members of the Sponsor. By virtue of this relationship, each of these individuals may be deemed to share beneficial ownership of the securities held of record by the Sponsor. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein."}],"balance_after":6249999,"source":{"system":"sec-edgar","filing":"0001104659-23-075256","document":"tm2319584-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000110465923075256/tm2319584-1_4seq1.xml","form_type":"4"}},{"id":2930699,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":111876,"kind":"organization","name":"MedTech Acquisition Sponsor LLC","position":1,"cik":"0001826760","reported_name":"MedTech Acquisition Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2020-12-28T17:30:36.000Z","date":"2020-12-22","kind":"other","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination on a one-for-one basis. The Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"As contemplated in connection with the initial public offering of the Issuer, 75,000 shares of Class B common stock of the Issuer were returned by the reporting person to the Issuer for no consideration and cancelled because the underwriters' over-allotment option was not exercised in full"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination on a one-for-one basis. The Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination on a one-for-one basis. The Class B common stock has no expiration date."}],"balance_after":6250000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-20-139623","document":"tm2039407d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000110465920139623/tm2039407d3_4.xml","form_type":"4"}}]}